[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Pages 34360-34361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12726]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB review; 30-day Comment Request;

    Request for Human Embryonic Stem Cell Line To Be Approved for Use 
in NIH Funded Research (OD)
SUMMARY: In compliance with the requirement of Section 3507(a) (1) (D) 
of the Paperwork Reduction Act of 1995, the National Institutes of 
Health (NIH) has submitted to the Office of Management and Budget (OMB) 
a request for review and approval of the information collection 
instrument listed below. This proposed information collection was 
previously published in the Federal Register on March 25, 2016, page 
16190 and allowed 60-days for public comment. No public comments were 
received. The purpose of this notice is to allow an additional 30 days 
for public comment. The NIH may not conduct or sponsor, and the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project contact: Dr. Ellen Gadbois, Office of Science Policy, 
Office of the Director, NIH, Building 1, Room 218, MSC 0166, 9000 
Rockville Pike, Bethesda, MD 20892, or call non-toll-free number (301) 
496-9838 or Email your request, including your address to: 
[email protected]. Formal requests for additional plans and 
instruments must be requested in writing.
    Proposed Collection: Request for Human Embryonic Stem Cell Line to 
be approved for Use in NIH Funded Research. OMB No. 0925-0601- 
Expiration Date 5/31/2016--Extension- Office of Extramural Research 
(OER), National Institutes of Health (NIH).
    Need and Use of Information Collection: The form is used by 
applicants to request that human embryonic stem cell lines be approved 
for use in NIH funded research. Applicants may submit applications at 
any time.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 2,550.

[[Page 34361]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per  per response (   Total annual
                                                    respondents     respondent       in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
NIH grantees and others with hESC lines.........              50               3              17           2,550
                                                 ---------------------------------------------------------------
    Total.......................................              50             150  ..............           2,550
----------------------------------------------------------------------------------------------------------------


    Dated: May 24, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016-12726 Filed 5-27-16; 8:45 am]
 BILLING CODE 4140-01-P